​​​
  1. Cadila Healthcare Ltd shares surge nearly 3% as Q2 net profit zooms 40%

Cadila Healthcare Ltd shares surge nearly 3% as Q2 net profit zooms 40%

Cadila Healthcare Ltd shares surged on Friday after the company posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.

By: | Updated: October 23, 2015 5:02 PM
Cadilla Healthcare stocks

Cadilla Healthcare posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16. (Reuters)

Pharma company Cadila Healthcare Ltd shares surged on Friday after the company posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.

At 10.06 am, the share price of the company was up 2.61 per cent at Rs 442.90. The BSE Sensex was up 209.35 points at 27,497.01 during the same time. Later, the share price of the company  closed 2.59 per cent up at Rs 442.85 on BSE.

Its total income has increased from Rs 2,122.61 crore for the quarter ended September 30 in the 2014-15 fiscal to Rs 2,483.19 crore in the second quarter of the current fiscal.

The company has posted standalone net profit of Rs 614.08 crore for the quarter ended September 30, 2015 as compared to Rs 365,61 crore in the year-ago period.

The standalone total income of the company has increased from Rs 1,396.6 crore for the year-ago quarter to Rs 1,976.45 crore July-September quarter.

In the consolidated results, other operating income for quarter ended on September 30, includes consideration Rs 20.03 crore ($3 million) received by Zydus Pharmaceuticals (USA) Inc. a wholly owned subsidiary company, on sale and transfer of ownership interest in certain Abbreviated New Drug Applications (ANDAs) for generic drug products.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top